Skip to main content
Equibles

Robert Lutz

iBio, Inc. (IBIO)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Robert Lutz

iBio, Inc. reported in an 8-K filed January 17, 2023 that Robert Lutz resigned as Chief Financial and Business Officer, effective February 10, 2023. iBio, Inc. reported in an 8-K filed December 2, 2022 that Robert Lutz was appointed Chief Financial and Business Officer (member of the office of the Chief Executive Officer), effective December 2, 2022. Robert Lutz has spoken on 1 earnings call across 1 company, most recently for iBio, Inc. on September 27, 2021.

“On January 11, 2023, Mr. Robert Lutz, the Chief Financial and Business Officer of iBio, Inc. (the "Company") provided the Company notice of his resignation as an executive officer of the Company, effective February 10, 2023.”
iBio, Inc. Form 8-K, filed January 17, 2023 · Read the filing
“On December 2, 2022, during the interim period while the Company continues its search of a new Chief Executive Officer, the Board approved the creation of the office of the Chief Executive Officer, whereby Mr. Robert Lutz, the Company's Chief Financial and Business Officer and Dr. Martin Brenner, the Company's Chief Scientific Officer will fill such role.”
iBio, Inc. Form 8-K, filed December 2, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at iBio, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.